(e)
include the EU trial number and information about the availability of the clinical trial results in accordance with paragraph 6.
← art_29__para_2__point_d__text_1 · All articles · art_29__para_2__point_e__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.